• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Snap Shares Jumped 7%; Here Are 75 Biggest Movers From Yesterday

    9/2/22 5:29:22 AM ET
    $AGIO
    $AI
    $AMD
    $AVCT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Computer Software: Prepackaged Software
    Technology
    Get the next $AGIO alert in real time by email

    Gainers

    • Hempacco Co., Inc. (NASDAQ:HPCO) shares jumped 63.4% to close at $8.35 after dropping 34% on Wednesday. Hempacco's common shares began trading on the Nasdaq Tuesday. The company had planned to offer 1 million shares of common stock at a public offering price of $6 per share for total gross proceeds of $6 million.
    • GigaCloud Technology Inc. (NASDAQ:GCT) climbed 61.4% to close at $23.65.
    • Virax Biolabs Group Limited (NASDAQ:VRAX) surged 58.7% to settle at $5.57.
    • Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX) jumped 51% to close at $20.24 after Novo Nordisk announced it will acquire the company for $20 per share in cash.
    • ShiftPixy, Inc. (NASDAQ:PIXY) surged 46.9% to close at $20.58 on Thursday. ShiftPixy announced a 1-for-100 reverse stock split.
    • Shuttle Pharmaceuticals, Inc. (NASDAQ:SHPH) shares surged 36.2% to close at $52.40 amid post-IPO volatility. The company priced its IPO at $8.125 per unit.
    • Kuke Music Holding Limited (NYSE:KUKE) jumped 32.9% to close at $1.13.
    • Nutanix, Inc. (NASDAQ:NTNX) gained 29.1% to close at $22.34 after the company reported better-than-expected sales results for its fourth quarter and issued strong revenue forecast.
    • InMed Pharmaceuticals Inc. (NASDAQ:INM) climbed 28.6% to close at $0.3060. InMed Pharmaceuticals recently announced a 1:25 share consolidation to meet Nasdaq listing criteria.
    • Eyenovia, Inc. (NASDAQ:EYEN) gained 25.2% to settle at $2.04.
    • Twin Disc, Incorporated (NASDAQ:TWIN) jumped 24.6% to close at $11.59 after the company posted a profit for the fourth quarter.
    • Immuneering Corporation (NASDAQ:IMRX) rose 24.6% to settle at $6.95.
    • Immuneering, last month, posted a Q2 loss of $0.44 per share.
    • Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) gained 23.2% to close at $2.18 after the company announced it has entered into a purchase agreement with Arena Business Solutions for up to $15 million of the company's common stock.
    • Meihua International Medical Technologies Co., Ltd. (NASDAQ:MHUA) jumped 22.4% to close at $4.75.
    • Alaunos Therapeutics, Inc. (NASDAQ:TCRT) rose 22.4% to close at $3.01.
    • Purple Innovation, Inc. (NASDAQ:PRPL) jumped 20.3% to settle at $3.44 after the company announced the acquisition of Intellibed.
    • Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) gained 20% to close at $30.59. Agios Pharmaceuticals, last month, reported better-than-expected Q2 EPS and sales results.
    • Werewolf Therapeutics, Inc. (NASDAQ:HOWL) jumped 19.6% to settle at $6.05. Werewolf Therapeutics initiated patient dosing in a Phase 1/1b clinical trial evaluating WTX-124, its lead INDUKINET molecule targeting IL-2 for the treatment of solid tumors.
    • RiceBran Technologies (NASDAQ:RIBT) gained 18.6% to close at $2.74. The company, last month, posted upbeat quarterly sales.
    • PaxMedica, Inc. (NASDAQ:PXMD) climbed 18.2% to close at $3.50. PaxMedica Executive Chairman, Director Michael Derby reported in Form4 filing purchase of 95,000 shares at $5.25 per share.
    • Belite Bio, Inc (NASDAQ:BLTE) jumped 14.3% to close at $36.70. Belite Bio recently announced it has commenced enrollment for the US Phase 3 clinical trial of LBS-008 in patients with Stargardt Disease.
    • Turquoise Hill Resources Ltd. (NYSE:TRQ) rose 13.9% to close at $31.30. Rio Tinto Group announced plans to acquire full ownership of Turquoise Hill Resources for C$43 per share in cash.
    • Bright Green Corporation (NASDAQ:BGXX) shares rose 12.3% to close at $1.55 after gaining around 33% on Wednesday.
    • Bausch Health Companies Inc. (NYSE:BHC) gained 10.4% to close at $6.59. RBC Capital maintained Bausch Health Companies with a Sector Perform and raised the price target from $4.5 to $8.
    • Relay Therapeutics, Inc. (NASDAQ:RLAY) climbed 8.4% to settle at $24.90. Stifel initiated coverage on Relay Therapeutics with a Buy rating and announced a price target of $40 today.
    • DXC Technology Company (NYSE:DXC) gained 7.8% to settle at $26.70.
    • Snap Inc. (NYSE:SNAP) jumped 7% to close at $11.64 after multiple analysts raised their price targets on the stock. The company on Wednesday announced restructuring plans and a workforce reduction.
    • Five Below, Inc. (NASDAQ:FIVE) rose 6.3% to close at $135.92 after the company reported Q2 earnings results.


    Losers

    • Addentax Group Corp. (NASDAQ:ATXG) shares dropped 95.4% to close at $30.00 following the company's uplisting and IPO.
    • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) dipped 52.2% to settle at $0.2200 after the company announced an equity distribution agreement to offer and sell up to $14.7 million shares of common stock.
    • NewAge, Inc. (NYSE:NBEV) dropped 46.9% to settle at $0.1222 on continued weakness after the company recently announced it filed a voluntary petition for relief under chapter 11 of the United States Bankruptcy Code.
    • Okta, Inc. (NASDAQ:OKTA) declined 33.7% to close at $60.60 after the company reported Q2 earnings results and issued Q3 and FY23 financial guidance. Several analysts also lowered their price targets on the stock.
    • Getty Images Holdings, Inc. (NYSE:GETY) fell 28.8% to close at $14.42.
    • Semtech Corporation (NASDAQ:SMTC) shares fell 27.2% to close at $33.65 after the company issued Q3 sales guidance below analyst estimates. Cowen & Co. and Oppenheimer also downgraded the stock.
    • Nogin, Inc. (NASDAQ:NOGN) dropped 25.7% to close at $2.5050.
    • MongoDB, Inc. (NASDAQ:MDB) shares fell 25.3% to close at $241.11 after the company issued earnings guidance below analyst estimates.
    • Greenpro Capital Corp. (NASDAQ:GRNQ) fell 24.8% to close at $1.91 after surging 63% on Wednesday.
    • Hour Loop, Inc. (NASDAQ:HOUR) dipped 24.7% to close at $3.20.
    • Rain Therapeutics Inc. (NASDAQ:RAIN) declined 19.9% to close at $4.75.
    • C3.ai, Inc. (NYSE:AI) fell 19.3% to close at $14.52 after the company reported worse-than-expected Q1 sales results and issued Q3 and FY23 sales guidance below analyst estimates.
    • Blackboxstocks Inc. (NASDAQ:BLBX) dropped 19.3% to settle at $0.96.
    • Codiak BioSciences, Inc. (NASDAQ:CDAK) declined 19.1% to settle at $1.74 after Goldman Sachs downgraded the stock from Buy to Neutral and lowered its price target from $6 to $2.
    • Akerna Corp. (NASDAQ:KERN) dipped 19% to settle at $0.1248.
    • Genesco Inc. (NYSE:GCO) fell 18.4% to close at $46.16 as the company lowered FY23 forecast.
    • NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) declined 18% to close at $2.09.
    • Bright Minds Biosciences Inc. (NASDAQ:DRUG) dropped 17.2% to settle at $1.59.
    • Nuwellis, Inc. (NASDAQ:NUWE) fell 16.4% to close at $1.22. Nuwellis shares jumped 121% on Wednesday after the company announced new clinical data demonstrating 100% survival at 30 days following the use of ultrafiltration in high-risk postoperative coronary artery bypass grafting patients.
    • Magic Empire Global Limited (NASDAQ:MEGL) dipped 16% to close at $6.53 after surging 33% on Wednesday.
    • Liquidia Corporation (NASDAQ:LQDA) fell 15.8% to close at $4.86 after Wedbush downgraded the stock from Neutral to Underperform and lowered its price target from $4 to $3.
    • GitLab Inc. (NASDAQ:GTLB) dipped 15.6% to close at $50.53.
    • Lands' End, Inc. (NASDAQ:LE) declined 15.3% to settle at $11.70 after the company issued Q3 EPS and sales and FY22 EPS guidance below estimates.
    • HashiCorp, Inc. (NASDAQ:HCP) fell 14.4% to close at $30.26.
    • Palatin Technologies, Inc. (NYSE:PTN) declined 14.3% to close at $4.30.
    • Veeva Systems Inc. (NYSE:VEEV) fell 14% to settle at $171.42 after the company issued Q3 and FY23 sales guidance below analyst estimates.
    • Mobilicom Limited (NASDAQ:MOB) declined 13.8% to close at $2.69 after gaining around 28% on Wednesday.
    • ZeroFox Holdings, Inc. (NASDAQ:ZFOX) shares fell 13.8% to close at $5.55 after surging around 19% on Wednesday.
    • Samsara Inc. (NYSE:IOT) fell 13% to close at $12.94 following Q3 results.
    • Signet Jewelers Limited (NYSE:SIG) fell 12% to close at $57.50 following Q2 results.
    • Polestar Automotive Holding UK PLC (NASDAQ:PSNY) fell 11.9% to close at $6.89. Polestar reported H1 sales of $1.04 billion.
    • Ciena Corporation (NYSE:CIEN) dipped 10.4% to settle at $45.48 after the company reported worse-than-expected Q3 sales results.
    • Enovix Corporation (NASDAQ:ENVX) declined 10% to close at $19.92.
    • Vicor Corporation (NASDAQ:VICR) fell 10% to settle at $64.05.
    • Fluence Energy, Inc. (NASDAQ:FLNC) fell 9.6% to close at $18.03.
    • KnowBe4, Inc. (NASDAQ:KNBE) declined 9.6% to close at $17.37.
    • DigitalOcean Holdings, Inc. (NASDAQ:DOCN) fell 8.9% to close at $38.33.
    • Zscaler, Inc. (NASDAQ:ZS) fell 8.6% to close at $145.57.
    • Stem, Inc. (NYSE:STEM) declined 8.4% to close at $14.40.
    • NVIDIA Corporation (NASDAQ:NVDA) fell 7.7% to close at $139.37 following a late Wednesday filing by the company that revealed that the U.S. government has communicated to it the need to secure a license for exporting its powerful AI processors such as the A100 and the yet-to-be-released H100 chips to China. This would prevent the export of these chips to China, one of its key markets.
    • Smartsheet Inc. (NYSE:SMAR) fell 7.4% to close at $30.82.
    • ThermoGenesis Holdings, Inc. (NASDAQ:THMO) fell 7% to close at $0.2284 after gaining 11% on Wednesday. ThermoGenesis, last month, posted a Q2 loss of $0.20 per share.
    • Hormel Foods Corporation (NYSE:HRL) fell 6.6% to close at $46.98 after the company posted downbeat Q3 earnings and lowered FY22 earnings forecast.
    • Monolithic Power Systems, Inc. (NASDAQ:MPWR) dipped 6.1% to close at $425.47.
    • SentinelOne, Inc.(NYSE:S) fell 5.9% to close at $25.70 after reporting Q2 results.
    • HIVE Blockchain Technologies Ltd. (NASDAQ:HIVE) fell 4.7% to close at $4.85 after gaining 4% on Wednesday.
    • Advanced Micro Devices, Inc (NASDAQ:AMD) fell 3% to close at $82.33 following news that the chipmakers were slapped with certain chip export restrictions to China.
    Get the next $AGIO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGIO
    $AI
    $AMD
    $AVCT

    CompanyDatePrice TargetRatingAnalyst
    Zscaler Inc.
    $ZS
    2/27/2026$315.00 → $210.00Outperform
    BMO Capital Markets
    C3.ai Inc.
    $AI
    2/26/2026Mkt Outperform → Mkt Perform
    Citizens
    Enovix Corporation
    $ENVX
    2/26/2026$15.00 → $7.50Hold
    TD Cowen
    MongoDB Inc.
    $MDB
    2/26/2026$455.00 → $400.00Outperform
    BMO Capital Markets
    Okta Inc.
    $OKTA
    2/26/2026$90.00 → $83.00Market Perform
    BMO Capital Markets
    Samsara Inc.
    $IOT
    2/25/2026$50.00 → $40.00Outperform
    BMO Capital Markets
    Polestar Automotive Holding UK PLC
    $PSNY
    2/19/2026Neutral → Underweight
    Cantor Fitzgerald
    Veeva Systems Inc.
    $VEEV
    2/17/2026$205.00Underweight → Equal-Weight
    Morgan Stanley
    More analyst ratings

    $AGIO
    $AI
    $AMD
    $AVCT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    March 22, 2024 - FDA Roundup: March 22, 2024

    For Immediate Release: March 22, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued an emergency use authorization for Pemgarda (pemivibart) for the pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and adolescents (12 years of age and older weighing at least 40 kilograms [about 88 pounds]).  Pemgarda is

    3/22/24 5:02:42 PM ET
    $SNAP
    $SRAX
    Computer Software: Programming Data Processing
    Technology
    Advertising
    Consumer Discretionary

    November 9, 2023 - FDA Approves First Treatment for Patients with Rare Inherited Blood Clotting Disorder

    For Immediate Release: November 09, 2023 Today, the U.S. Food and Drug Administration approved Adzynma, the first recombinant (genetically engineered) protein product indicated for prophylactic (preventive) or on demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP), a rare and life-threatening blood clotting disorder. “The FDA remains

    11/9/23 2:30:20 PM ET
    $SRAX
    $SNAP
    Advertising
    Consumer Discretionary
    Computer Software: Programming Data Processing
    Technology

    $AGIO
    $AI
    $AMD
    $AVCT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Batten John H gave a grant of 6,000 shares (SEC Form 4)

    4 - TWIN DISC INC (0000100378) (Issuer)

    2/27/26 7:15:33 PM ET
    $TWIN
    Industrial Machinery/Components
    Industrials

    Chief Financial Officer Tighe Brett was granted 64,798 shares, increasing direct ownership by 48% to 199,183 units (SEC Form 4)

    4 - Okta, Inc. (0001660134) (Issuer)

    2/27/26 5:25:38 PM ET
    $OKTA
    Computer Software: Prepackaged Software
    Technology

    Officer Schwartz Larissa was granted 44,930 shares, increasing direct ownership by 124% to 81,258 units (SEC Form 4)

    4 - Okta, Inc. (0001660134) (Issuer)

    2/27/26 5:24:38 PM ET
    $OKTA
    Computer Software: Prepackaged Software
    Technology

    $AGIO
    $AI
    $AMD
    $AVCT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    DigitalOcean to Participate in Morgan Stanley Technology, Media & Telecom Conference

    DigitalOcean Holdings, Inc. (NYSE:DOCN), the Agentic Inference Cloud built for production AI, today announced that Chief Executive Officer Paddy Srinivasan and Chief Financial Officer Matt Steinfort will participate in a fireside chat at the Morgan Stanley Technology, Media & Telecom Conference on Tuesday, March 3rd, 2026 at 7:45 a.m. (PT) / 10:45 a.m. (ET). A live webcast and replay will be available on DigitalOcean's investor relations website at investors.digitalocean.com. About DigitalOcean DigitalOcean is the Agentic Inference Cloud built for AI-native and Digital-native enterprises scaling production workloads. The platform combines production-ready GPU infrastructure with a ful

    2/27/26 9:00:00 AM ET
    $DOCN
    Computer Software: Programming Data Processing
    Technology

    Relay Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Outlines Anticipated 2026 Milestones

    Initial Phase 1 data of zovegalisib in PIK3CA-driven vascular anomalies expected to be announced in first half of 2026 Breast cancer triplet data and frontline Phase 3 plans expected to be announced in 2026 Initial Phase 1/2 data of zovegalisib + fulvestrant at 400mg BID fed (Phase 3 dose) in CDK4/6-experienced patients to be presented at ESMO TAT on March 16, 2026 Approximately $555 million in cash, cash equivalents and investments at end of Q4 2025 CAMBRIDGE, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (NASDAQ:RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and gen

    2/26/26 4:05:00 PM ET
    $RLAY
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Semtech to Showcase IoT Portfolio at MWC26 Barcelona

    IoT connectivity leader demonstrates portfolio spanning low-power LoRa® to 5G RedCap Semtech Corporation (NASDAQ:SMTC), a leading provider of high-performance semiconductor, Internet of Things (IoT) systems and cloud connectivity service solutions, today announced its participation in MWC26 Barcelona, taking place Mar. 2–5, 2026. Semtech will showcase its latest IoT innovations in its Executive Meeting Room 7B4Ex in Hall 7, where attendees can meet with experts across the company's cellular IoT and LoRa technology portfolio. "Semtech has a proven track record as a global IoT connectivity leader, and MWC26 Barcelona gives us the opportunity to bring our expertise directly to the customer

    2/26/26 4:05:00 PM ET
    $SMTC
    Semiconductors
    Technology

    $AGIO
    $AI
    $AMD
    $AVCT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Fernandez Raul J bought $250,706 worth of shares (16,446 units at $15.24), increasing direct ownership by 2% to 816,001 units (SEC Form 4)

    4 - DXC Technology Co (0001688568) (Issuer)

    2/3/26 5:55:04 PM ET
    $DXC
    EDP Services
    Technology

    Chief Business Officer Brakewood Harold Eugene bought $24,990 worth of shares (5,250 units at $4.76), increasing direct ownership by 91% to 11,050 units (SEC Form 4)

    4 - Immuneering Corp (0001790340) (Issuer)

    1/21/26 9:09:57 AM ET
    $IMRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Schall Thomas J. bought $101,041 worth of shares (21,645 units at $4.67), increasing direct ownership by 41% to 74,530 units (SEC Form 4)

    4 - Immuneering Corp (0001790340) (Issuer)

    1/20/26 9:17:29 AM ET
    $IMRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGIO
    $AI
    $AMD
    $AVCT
    SEC Filings

    View All

    SEC Form DEFR14C filed by Greenpro Capital Corp.

    DEFR14C - Greenpro Capital Corp. (0001597846) (Filer)

    2/27/26 4:45:04 PM ET
    $GRNQ
    EDP Services
    Technology

    SEC Form 10-K filed by Monolithic Power Systems Inc.

    10-K - MONOLITHIC POWER SYSTEMS INC (0001280452) (Filer)

    2/27/26 4:33:25 PM ET
    $MPWR
    Semiconductors
    Technology

    Monolithic Power Systems Inc. filed SEC Form 8-K: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

    8-K - MONOLITHIC POWER SYSTEMS INC (0001280452) (Filer)

    2/27/26 4:31:27 PM ET
    $MPWR
    Semiconductors
    Technology

    $AGIO
    $AI
    $AMD
    $AVCT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets reiterated coverage on Zscaler with a new price target

    BMO Capital Markets reiterated coverage of Zscaler with a rating of Outperform and set a new price target of $210.00 from $315.00 previously

    2/27/26 8:09:31 AM ET
    $ZS
    EDP Services
    Technology

    C3.ai downgraded by Citizens

    Citizens downgraded C3.ai from Mkt Outperform to Mkt Perform

    2/26/26 7:10:22 AM ET
    $AI
    Computer Software: Prepackaged Software
    Technology

    TD Cowen reiterated coverage on Enovix with a new price target

    TD Cowen reiterated coverage of Enovix with a rating of Hold and set a new price target of $7.50 from $15.00 previously

    2/26/26 6:56:07 AM ET
    $ENVX
    Industrial Machinery/Components
    Miscellaneous

    $AGIO
    $AI
    $AMD
    $AVCT
    Leadership Updates

    Live Leadership Updates

    View All

    Nuwellis Appoints David A. McDonald and Martin J. Emerson to Board of Directors

    MINNEAPOLIS, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced the appointment of David A. McDonald and Martin J. Emerson to its Board of Directors, effective February 24, 2026. The appointments strengthen the Company's board with complementary expertise in public company leadership, capital markets, and medical device commercialization. "These appointments reflect our continued focus on operational discipline and long-term value creation," said John Erb, President and CEO of Nuwellis. "Marty has led multiple medical device organizations through scali

    2/26/26 8:00:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Hormel Foods Appoints Donald Monk as Company's First Chief Technology Officer

    New role underscores company's commitment to modernizing technology, digital and data capabilitiesAUSTIN, Minn., Feb. 24, 2026 /PRNewswire/ -- Hormel Foods Corporation (NYSE:HRL), a Fortune 500 global branded food company, today announced the appointment of Donald Monk as chief technology officer, effective March 23. In this newly created role, Monk will serve as the company's senior-most technology leader, responsible for envisioning, aligning and delivering the enterprise technology, digital and data strategy that supports long‑term growth. "Don is an exceptional technology le

    2/24/26 4:30:00 PM ET
    $HRL
    Meat/Poultry/Fish
    Consumer Staples

    Establishment Labs Announces Leadership Transition to Support Next Phase of Growth

    Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced a strategic leadership transition of Raj Denhoy, current Chief Financial Officer to Senior Vice President, Global Strategy, and the appointment of Cassandra "Sandra" Harris to Senior Vice President and Chief Financial Officer, effective March 9, 2026. "Over the past few years, we have been focused on driving efficient execution and scalability. With the company well positioned for its next chapter of growth, we are creating additional leadership capacity to maintain operational momentum

    2/24/26 8:00:00 AM ET
    $ESTA
    $GCO
    Industrial Specialties
    Health Care
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $AGIO
    $AI
    $AMD
    $AVCT
    Financials

    Live finance-specific insights

    View All

    Zscaler Announces Strong Second-Quarter Fiscal 2026 Results; Raises Fiscal 2026 ARR Guidance to 24%

    Exceeds high-end of second-quarter guidance on revenue and profitability metrics Second Quarter Highlights Revenue grew 26% year-over-year to $815.8 millionAnnual Recurring Revenue ("ARR") grew 25% year-over-year to $3,359 millionOperating cash flow grew 14% year-over-year to $204.1 millionFree cash flow grew 18% year-over-year to $169.1 million SAN JOSE, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Zscaler, Inc. (NASDAQ:ZS), the leader in cloud security, today announced financial results for its second quarter of fiscal year 2026, ended January 31, 2026. "We believe Zscaler is the cybersecurity platform for the AI age - our in-line Zero Trust platform is uniquely architected to secure th

    2/26/26 4:05:00 PM ET
    $ZS
    EDP Services
    Technology

    HORMEL FOODS REPORTS FIRST QUARTER FISCAL 2026 RESULTS

    Company Achieves Net Sales of $3 billion and Organic Net Sales1 Growth of 2%Company Reports Diluted EPS of $0.33; Adjusted Diluted EPS1 of $0.34Updates GAAP Guidance; Reiterates Adjusted Full Year Fiscal 2026 GuidanceAUSTIN, Minn., Feb. 26, 2026 /PRNewswire/ -- Hormel Foods Corporation (NYSE:HRL), a Fortune 500 global branded food company, today reported results for the first quarter of fiscal 2026, which ended January 25, 2026. All comparisons are to the comparable period of fiscal 2025, unless otherwise noted. EXECUTIVE SUMMARY — FIRST QUARTERNet sales of $3.03 billion; organi

    2/26/26 6:30:00 AM ET
    $HRL
    Meat/Poultry/Fish
    Consumer Staples

    NVIDIA Announces Financial Results for Fourth Quarter and Fiscal 2026

    Record quarterly revenue of $68.1 billion, up 20% from Q3 and up 73% from a year agoRecord quarterly Data Center revenue of $62.3 billion, up 22% from Q3 and up 75% from a year agoRecord full-year revenue of $215.9 billion, up 65% SANTA CLARA, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- NVIDIA (NASDAQ:NVDA) today reported record revenue for the fourth quarter ended January 25, 2026, of $68.1 billion, up 20% from the previous quarter and up 73% from a year ago. For fiscal 2026, revenue was $215.9 billion, up 65% from a year ago. For the quarter, GAAP and non-GAAP gross margins were 75.0% and 75.2%, respectively. For fiscal 2026, GAAP and non-GAAP gross margins were 71.1% and

    2/25/26 4:31:17 PM ET
    $NVDA
    Semiconductors
    Technology

    $AGIO
    $AI
    $AMD
    $AVCT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by SentinelOne Inc.

    SC 13D/A - SentinelOne, Inc. (0001583708) (Subject)

    12/12/24 6:30:27 PM ET
    $S
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Samsara Inc.

    SC 13D/A - Samsara Inc. (0001642896) (Subject)

    12/11/24 9:27:25 PM ET
    $IOT
    EDP Services
    Technology

    Amendment: SEC Form SC 13D/A filed by Eyenovia Inc.

    SC 13D/A - EYENOVIA, INC. (0001682639) (Subject)

    12/4/24 4:12:20 PM ET
    $EYEN
    Biotechnology: Pharmaceutical Preparations
    Health Care